Skip to content

A verification study on effect of functional sweetener ingestion for 2 months on plasma biomarkers

A verification study on effect of functional sweetener ingestion for 2 months on plasma biomarkers - Allu trail to lipid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1090220296
Enrollment
15
Registered
2017-06-06
Start date
2017-06-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects with moderately high blood glucose and lipid levels

Interventions

Sponsors

Matsutani Chemical Industry Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Borderline diabetic: Screened based on fasting blood glucose levels from 110 mg/dl and below 126 mg/dl, or HbA1c(NGSP) levels from 6.2% and below 6.5% High LDL-C subject: LDL-C levels from 120 mg/dl and below 160 mg/dl

Exclusion criteria

Exclusion criteria: 1) Subjects suffering from serious diseases 2) Subjects had intestinal surgeries 3) Subjects using medications to control blood glucose and lipid levels 4) Subjects how are allergic to oligosaccharides and sweeteners 5) Subjects using functional foods to control blood glucose and lipid levels 6) Subjects participate in other clinical trials (food material, medicine, cosmetics, liniment) 7) Subjects who are judged as unsuitable for this study by principal investigator

Design outcomes

Primary

MeasureTime frame
Serum lipid levels(triglyceride, cholesterol and apoprotein levels)

Secondary

MeasureTime frame
Blood glucose, insulin and bile acid levels

Countries

Japan

Contacts

Public ContactNoriko Hayashi

Matsutani Chemical Industry Co., Ltd.

noriko-hayashi@matsutani.co.jp+81-72-771-2052

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026